Defining the Therapeutic Range for Adalimumab and Predicting Response in Psoriasis: A Multicenter Prospective Observational Cohort Study. (2019)

First Author: Wilkinson N
Attributed to:  MICA: The Newcastle Proximity Laboratory funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.jid.2018.07.028

PubMed Identifier: 30130616

Publication URI: http://europepmc.org/abstract/MED/30130616

Type: Journal Article/Review

Volume: 139

Parent Publication: The Journal of investigative dermatology

Issue: 1

ISSN: 0022-202X